American International Group’s Allena Pharmaceuticals ALNA Stock Holding History

American International Group’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,394	Closed	-$52K	–	3187
2019 Q1	$52K	Sell	7,394 -238	-3%	-$1.73K	﹤0.01%	2866
2018 Q4	$42K	Sell	7,632 -59	-0.8%	-$509	﹤0.01%	2929
2018 Q3	$83K	Buy	7,691 +138	+2%	+$1.52K	﹤0.01%	2925
2018 Q2	$98K	Buy	7,553 +4,108	+119%	+$59.2K	﹤0.01%	2801
2018 Q1	$38K	Sell	3,445 -185	-5%	-$1.54K	﹤0.01%	2946
2017 Q4	$37K	Buy	+3,630	New	+$44.7K	﹤0.01%	2975

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's ALNA Position: Q2 2019 in Review

American International Group sold out of Allena Pharmaceuticals (ALNA) in Q2 2019, closing a stake of 7,394 shares — an estimated $52K sold.

American International Group first reported a position in ALNA in Q4 2017 and held it in 6 quarters. The position peaked at $98K in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q2 2019.

American International Group reported no remaining Allena Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
American International Group sold 7,394 Allena Pharmaceuticals shares in Q2 2019, an estimated $52K.
American International Group first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 6 quarters.
American International Group's Allena Pharmaceuticals position peaked at $98K in Q2 2018.
46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.